News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech

News
Magazine
Markets
In Depth
Economy & Policy
Videos
Start-Up
Planet
Corporate
Tech
Spotlight

home
Topic
Piramal pharma

Piramal Pharma

Piramal Group

Piramal Pharma Stock Surges 8% on Impressive Q2 Revenue Growth

BY Outlook Business Desk

Piramal Group

Piramal Pharma Board Approves Rs 1,050 Rights Issue At Rs 81 Per Share

BY Outlook Business Desk

Protesting Against Online Pharmacy, Chemists Observe Nationwide Shutdown Today

Piramal Pharma's Rs 1,050-Cr Rights Issue Gets Sebi's Nod

BY PTI

Piramal Pharma Reports Consolidated Net Loss Of Rs 90 Cr In Q3

Piramal Pharma Reports Consolidated Net Loss Of Rs 90 Cr In Q3

BY PTI

Piramal Pharma Locked In 5% Lower Circuit On Listing After Demerger

Piramal Pharma Locked In 5% Lower Circuit On Listing After Demerger

BY Outlook Business Team

Pharmaceutical Sector.

Piramal Pharma Ropes In Ajay Devgn For Brand Tetmosol

BY Press Trust of India

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2024 Outlook Publishing India Pvt Ltd.

Copyright © 2024 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.